The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20150025: Centerbridge Capital Partners II, L.P.; Bluestem Brands, Inc.
20150026: Capmark Financial Group Inc.; Bluestem Brands, Inc.
20141615: The Walt Disney Company; Shane Smith
20141618: The Hearst Family Trust; Shane Smith
20141656: The Weir Group PLC; Navis Asia Fund V, L.P.
20141660: Sola Ltd, Charitable Trust; TerreStar Corporation
20141661: UnitedHealth Group Incorporated; MedSynergies, Inc.
20141662: Smurfit Kappa Group plc; The Sanders Family 2011 Irrevocable Trust
20141669: Riverstone Global Energy and Power Fund V (FT), L.P.; Mr. John B. Fitzgibbons
20141673: Eugene Kashper; Pabst Corporate Holdings, Inc.
20150003: EquiPower Resources Corp.; Electric Power Development Co., Ltd.
20150007: Blackhawk Network Holdings, Inc.; Parago, Inc.
20150008: Sun Pharmaceutical Industries Ltd.; Merck & Co., Inc.
20150015: AP ESP Holdings LP; Express Energy Services, LLC
20150016: Laboratory Corporation of America Holdings; LipoScience, Inc.
20150024: Fresenius Medical Care AG & Co. KGaA; Bain Capital Venture Fund 2009, L.P.
20150031: Encana Corporation; Athlon Energy Inc.
Prestige Brands Holdings, Inc. and Insight Pharmaceuticals Corporation, In the Matter of
Pharmaceutical company Prestige Brands Holdings, Inc., the maker of Dramamine, agreed to divest assets and marketing rights for the over-the-counter motion sickness drug Bonine to settle FTC charges that Prestige’s proposed acquisition of Insight Pharmaceuticals Corporation would likely be anticompetitive. Prestige proposed to acquire Insight for $750 million. According to the FTC’s complaint, Prestige’s Dramamine, which is the best-selling branded product in the market for over-the-counter motion-sickness drugs, and Insight’s Bonine, are the only two branded products with significant sales. Absent a remedy, the acquisition would eliminate the close competition between Dramamine and Bonine, likely leading to higher prices for consumers.